Antipodes Partners LTD Alcon Inc Transaction History
Antipodes Partners LTD
- $3.16 Billion
- Q1 2025
A detailed history of Antipodes Partners LTD transactions in Alcon Inc stock. As of the latest transaction made, Antipodes Partners LTD holds 1,195,712 shares of ALC stock, worth $104 Million. This represents 3.59% of its overall portfolio holdings.
Number of Shares
1,195,712
Previous 1,145,362
4.4%
Holding current value
$104 Million
Previous $97.2 Million
16.74%
% of portfolio
3.59%
Previous 3.42%
Shares
3 transactions
Others Institutions Holding ALC
# of Institutions
767Shares Held
247MCall Options Held
2.25MPut Options Held
3.94M-
Vanguard Group Inc Valley Forge, PA20.1MShares$1.75 Billion0.04% of portfolio
-
Credit Suisse Ag Zurich, V815.5MShares$1.34 Billion1.27% of portfolio
-
Aristotle Capital Management, LLC Los Angeles, CA12.2MShares$1.06 Billion2.43% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL11.7MShares$1.02 Billion0.29% of portfolio
-
Zurcher Kantonalbank (Zurich Cantonalbank) Zurich, V88.51MShares$740 Million2.39% of portfolio
About ALCON INC
- Ticker ALC
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 490,087,008
- Market Cap $42.6B
- Description
- Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...